Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 611,898 |
|
|||||
| News | (1) | ||||||
| Day High | 18.14 | Low High |
|||||
| Day Low | 17.04 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.905 | 5.29% | 18.00 | 19:32:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.10 | 17.04 | 18.14 | 17.68 | 17.095 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,905 | 611,898 | $ 17.76 | $ 10,868,336 | - | 10.645 - 22.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:57:30 | 98 | $ 18.00 | USD |
Kiniksa Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.25B | 70.62M | - | 270.26M | 14.08M | 0.20 | 88.52 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kiniksa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.38 | 18.14 | 16.56 | 17.04 | 368,107 | 0.62 | 3.57% |
| 1 Month | 20.21 | 20.25 | 16.56 | 18.07 | 352,805 | -2.21 | -10.94% |
| 3 Months | 18.39 | 22.10 | 16.56 | 19.45 | 369,214 | -0.39 | -2.12% |
| 6 Months | 15.52 | 22.10 | 14.12 | 18.16 | 425,729 | 2.48 | 15.98% |
| 1 Year | 11.61 | 22.10 | 10.645 | 17.14 | 432,771 | 6.39 | 55.04% |
| 3 Years | 16.78 | 22.10 | 7.36 | 14.22 | 392,037 | 1.22 | 7.27% |
| 5 Years | 16.36 | 33.00 | 5.01 | 15.30 | 353,593 | 1.64 | 10.02% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. |
